Worldwide Demand For Autologous Fat Grafting Is Projected To Expand At A Healthy CAGR of Close To 10% By 2031

The global autologous fat grafting market is projected to expand at a healthy CAGR of close to 10% from 2021 to 2031. By application, breast augmentation holds the highest market share of over 45%.

Autologous fat grafting systems are used for precise and faster fat processing, which eliminates the use of laborious manual procedures. This makes the overall fat grafting process effective and more affordable. Autologous fat transfer systems and accessories find major application in minimal and non-invasive cosmetic procedures.

To remain ‘ahead’ of your competitors, request a sample:

https://www.factmr.com/connectus/sample?flag=S&rep_id=2701

Key Takeaways from Market Study

  • Integrated fat transfer systems accounted for over 50% of market share in 2020.
  • Breast augmentation is the most lucrative segment and holds a little less than half of the market share.
  • North America accounts for over half of the global autologous fat grafting market share, owing to technological advancements and increasing research & development activities in this region.
  • Hospitals account for over 48% value share, among end users.
  • The COVID19 pandemic has resulted in a temporary pause of all non-essential and elective procedures. Pharmaceutical manufacturers have been severely impacted, with companies reporting a significant drop in revenue due to supply chain issues.
  • The market in the U.S., U.K. and Germany to accelerate at around 10% CAGR each through 2031.
  • The market in China to surge ahead at a CAGR of around 12% over the next ten years.

“Increasing prevalence of scar contractures and growing acceptance of aesthetic cosmetic procedures are expected to drive demand for integrated fat transfer systems over the coming years,”says a Fact.MR analyst.

Prominent Key players of the Autologous Fat Grafting market survey report:

  • AbbVie Inc. (Allergan plc)
  • Sisram Medical, Ltd (Alma Lasers)
  • Plus Therapeutics, Inc. (Cytori Therapeutics, Inc.)
  • Genesis Biosystems, Inc.
  • Black Tie Medical Inc. (Tulip Medical Inc.)
  • Ranfac Corp.
  • HK Surgical Inc.
  • MicroAire Surgical Instruments, LLC
  • Innovia Medical Inc.
  • Human Med AG.
  • Sterimedix Ltd
  • Proteal Bioregenerative Solutions
  • Medikan International Inc.

Speak To Research Analyst For Detailed Insights:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=2701

Key Segments of Market

PRODUCT

  • Integrated Fat Transfer Systems
  • Aspiration and Harvesting Systems
  • Liposuction Systems
  • Fat Processing Systems
  • De-epithelialization Devices
  • Accessories
    • Fat Injection Cannulas
    • Fat Harvesting Cannulas
    • LuerLok Infiltrator Cannulas
    • Cannula Connectors & Single Use Fat Transfer
    • Tubing Sets

APPLICATION

  • Autologous Fat Grafting for Breast Augmentation
  • Autologous Fat Grafting for Buttock Augmentation
  • Facial Fat Grafting
  • Autologous Fat Grafting for Hand Rejuvenation
  • Others

END USER

  • Autologous Fat Grafting at Hospitals
  • Autologous Fat Grafting at On-site Clinics
  • Autologous Fat Grafting at Plastic Surgery Centers

REGION

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa

Full Access of this Report Is Available at:

https://www.factmr.com/checkout/2701

Questionnaire answered in the Autologous Fat Grafting Market report include:

  • How the market for Autologous Fat Grafting has grown?
  • What is the present and future outlook of the global Autologous Fat Grafting on the basis of region?
  • What are the challenges and opportunities for the Autologous Fat Grafting?
  • Why the consumption of Autologous Fat Grafting highest in region?
  • In which year segment is expected to overtake segment?

Read Our Latest Article on Healthcare Domain 

https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

contact:

21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea
Phone: +1 (628) 251-1583
Email: [email protected]